Best Lung Cancer Doctors in the UK for Early Detection and Treatment
Lung cancer remains one of the most frequently diagnosed and most serious cancers in the United Kingdom, with tens of thousands of new cases recorded each year. For much of the twentieth century, the prognosis for patients was sobering, largely because the disease was rarely caught before it had already progressed. Today, that picture is changing. The combination of greater public awareness, improved imaging technology, and a new generation of targeted and immunotherapy treatments means that patients who engage with expert care early have a genuinely meaningful chance of achieving durable remission or, in some cases, cure.
The choice of specialist is one of the most consequential decisions a patient or family can make. The most effective lung cancer care tends to come from oncologists who possess both deep clinical expertise and rapid access to the latest diagnostic and therapeutic tools. The practitioners listed below are among the most highly regarded lung cancer oncologists practicing in the UK today, drawn from different regions and clinical backgrounds to reflect the breadth of excellent care available across the country.
Dr Crispin Hiley: Consultant Oncologist at University College London Hospital
Dr Crispin Hiley is a Consultant Oncologist at University College London Hospital (UCLH) and an Associate Professor in Oncology at University College London, where his academic and clinical work proceed in close parallel. He is also the Clinical Director for Lung Cancer at GenesisCare UK, one of the country's largest specialist oncology provider networks, a role that reflects both his seniority within the field and his broader influence over how thoracic oncology services are structured and delivered. His background combines rigorous academic research with active clinical practice, and he is recognised across the oncology community as a significant and forward-looking figure in the management of lung cancer.
Proton Therapy and Translational Research
One of Dr Hiley's most notable distinctions is his role as UCLH Lead for Lung Proton Therapy. He was the first oncologist in the United Kingdom to use proton beam technology for lung cancer radiation treatment, a milestone that speaks to his commitment to bringing emerging therapies into clinical practice at the earliest viable point. His research interests lie within translational oncology, the work that bridges laboratory discovery and real-world patient care, and he has published extensively in peer-reviewed journals on lung cancer biology, genomics, and treatment response. For patients whose cases may benefit from or require proton therapy, Dr Hiley's combination of pioneering clinical experience and robust academic grounding makes him a particularly considered choice.
Practice Scope and Patient Profile
Dr Hiley sees patients through his UCLH and GenesisCare platforms, with the infrastructure of two of the UK's most established cancer care networks supporting his clinical work. His patient profile tends toward those with complex or research-adjacent presentations, in part because of his academic prominence and in part because of his known expertise in novel radiation techniques and genomically informed treatment strategies. He treats both non-small cell and small cell lung cancer, with a particular research and clinical interest in the molecular and immunological drivers of treatment response. For patients who want a specialist simultaneously embedded in current research and active in routine clinical management, Dr Hiley offers a well-credentialed and academically grounded option within the London oncology landscape.
It is fair to note that Dr Hiley works within a team-based model at UCLH and GenesisCare, which, for some patients, shapes the consultation experience differently from that of a solo private practitioner. His academic and leadership commitments are a marker of his professional standing, and they also mean that patients engaging with his practice do so within a broader institutional framework. The depth of clinical and scientific thinking he brings to each case is, by all accounts, high, and his contribution to establishing proton therapy as a viable and accessible option for lung cancer patients in the UK is a meaningful part of his professional profile.
Dr James Wilson: Consultant Clinical Oncologist, London
Dr James Wilson is a London-based Consultant Clinical Oncologist who has built a reputation as one of the foremost lung cancer specialists in the country. His training is extraordinarily well-rounded: he studied at the University of Oxford, completed clinical training at the Royal Marsden Hospital (the UK's leading dedicated cancer centre), and undertook further specialist training at Massachusetts General Hospital in Boston, one of the top cancer institutions in the world. Few practitioners in the UK combine that calibre of academic foundation with an active private practice that offers patients same-day or next-day appointments, with no GP referral required. He holds his NHS post at University College London Hospitals NHS Trust and also sees private patients at The London Clinic, the Cromwell Hospital, and Proton International London, among other leading facilities.
A Truly Dual-Qualified Specialist
What sets Dr Wilson apart from the majority of oncologists in the UK is his dual qualification in both medical oncology and clinical oncology. This means he is fully trained not only in systemic drug therapies, including immunotherapy using checkpoint inhibitors, targeted molecular treatments, and precision chemotherapy, but also in the full spectrum of advanced radiotherapy techniques. In practice, this allows him to evaluate a patient's complete clinical picture and design a personalised treatment plan without requiring referral to a separate specialist for one half of the pathway. For patients with early-stage lung cancer in particular, where the decision between surgical approaches, stereotactic radiotherapy, and systemic therapy can be nuanced and multifactorial, having a single consultant who commands all perspectives from the outset is a rare and significant advantage.
Treatment Technology and Reported Outcomes
Dr Wilson's treatment repertoire includes some of the most advanced technologies currently available in oncology. He offers Stereotactic Ablative Radiotherapy (SABR and SBRT), proton beam therapy, CyberKnife, and MR Linac radiotherapy, all of which deliver highly targeted radiation with minimal impact on surrounding healthy tissue. His reported tumour control rate of over 90% for SABR procedures reflects both the precision of the technology and the rigour with which it is applied in his practice. Alongside these radiotherapy capabilities, he provides molecularly targeted drug therapies and immunotherapy for patients whose tumours carry specific genetic markers, as well as rapid-access diagnostics including PET scans, molecular profiling, and liquid biopsies. This means patients can move from first consultation through to confirmed diagnosis and an active treatment plan with unusual speed.
The practical experience of seeing Dr Wilson is equally well-considered. Same-day or next-day appointments are available, video consultations are offered for those unable to attend in person, and both private health insurance and self-pay arrangements are accepted. His work has been featured across national media including the BBC, ITV, The Telegraph, and the Mail on Sunday, reflecting the trust that patients, referring clinicians, and medical journalists place in his expertise. For anyone facing a new lung cancer diagnosis, or reconsidering an existing treatment plan, his practice is structured to provide clarity and clinical momentum at precisely the moment when both matter most.
Professor Hany Eldeeb: Consultant Medical and Clinical Oncologist in Northampton and Oxford
Professor Hany Eldeeb is a Consultant Medical and Clinical Oncologist practicing across Northampton, Milton Keynes, and Oxfordshire, making him one of the most senior lung cancer specialists accessible outside of London. He holds the dual designation of both medical and clinical oncologist, and his clinical practice reflects a wide command of systemic and radiotherapy-based treatments for lung cancer. His approach integrates gene-sequenced-based therapy, immunotherapy, targeted treatment, precision chemotherapy, and contemporary radiotherapy techniques, covering both the biological and radiation-based dimensions of modern thoracic oncology management.
Molecular Therapy and a Precision Medicine Approach
A substantial part of Professor Eldeeb's practice is orientated around the biological treatment of lung cancer, particularly for patients whose tumours carry identifiable genetic mutations or immune-biomarker profiles. The use of gene-sequencing to guide treatment selection is one of the most significant recent advances in thoracic oncology, and its integration into routine practice requires both current knowledge and access to the appropriate diagnostic infrastructure. Professor Eldeeb has built his practice around this precision medicine model, meaning patients with EGFR mutations, ALK rearrangements, PD-L1 expression, or other biomarker-driven presentations can expect a treatment plan that is specifically tailored to the molecular characteristics of their individual tumour.
Regional Reach and Multi-Site Practice
One of the more practical advantages of Professor Eldeeb's practice is its geographic spread. Patients across the Midlands and South East who are unable or unwilling to travel to London for oncology consultations have in Professor Eldeeb a consultant-level specialist available within commutable distance. He practices across several sites in his listed locations, and the scope of his clinical offering is fully comparable to what one might expect from a London-based private oncologist. His dual qualifications mean that, like a small number of specialists in the UK, he is positioned to offer an integrated view of treatment options without patients needing to be referred between separate specialty consultants.
Professor Eldeeb's broader oncological background encompasses both breast and lung cancer, and while lung cancer is a principal focus of his thoracic practice, that wider experience lends him a rounded perspective on complex cases where multiple clinical factors are in play. Patients who have been seen at other centres, or who carry a secondary diagnosis alongside a thoracic malignancy, may find his multi-specialty experience particularly relevant. He accepts patients on a private basis across his catchment region, as well as those willing to travel for a consultation with a senior academic clinician working at this level of the specialty.
Dr Craig Knighton: Consultant Clinical Oncologist in Northampton and Milton Keynes
Dr Craig Knighton is a Consultant Clinical Oncologist who leads the oncology team across Northampton and Milton Keynes, combining clinical practice, departmental leadership, and patient care across two of the region's key healthcare settings. He trained at Guy's and St Thomas' Hospitals in London, institutions with national and international reputations in cancer medicine, and has built a practice in the East Midlands that reflects that rigorous clinical grounding. His specialties include lung cancer, breast cancer, brain tumours, and head and neck cancers, with lung cancer occupying a prominent and well-established place within his private caseload.
Expertise in Lung Cancer Diagnosis and Management
Dr Knighton's expertise in the diagnosis and management of lung cancer has been recognised both locally and at a broader professional level. He performs private consultations and treatments at the Three Shires Hospital in Northampton, Northampton General Hospital, and GenesisCare in Milton Keynes, ensuring that patients across the region can access his care without the need to travel to a major metropolitan centre. His clinical work covers the full pathway from initial diagnosis and staging through to active treatment planning, and he is conversant with the molecular and radiological tools central to modern thoracic oncology. For patients in Northamptonshire and the surrounding counties, his practice offers a standard of specialist lung cancer expertise more commonly associated with London or Manchester.
A Multidisciplinary Approach to Patient Care
One of the notable aspects of Dr Knighton's practice is the way his team leadership role situates him within a broader multidisciplinary framework. Heading the oncology department at his NHS trust while maintaining a parallel private practice gives him consistent exposure to a wide range of cases and treatment pathways, and this breadth of clinical experience tends to inform decision-making in ways that benefit private patients as well. Those who come to him privately benefit from a consultant who is simultaneously managing complex NHS cases and offering the personalised attention that private oncology practice allows.
For patients seeking a lung cancer oncologist who combines the rigour of London-trained expertise with the practical advantages of a regional practice, Dr Knighton represents a credible and well-regarded option. His dual institutional base across Northampton and Milton Keynes, together with his access to GenesisCare's clinical infrastructure, means that patients in central England can access treatment modalities including advanced radiotherapy without necessarily making the journey to the capital. The confidence that local GPs and referring clinicians place in him through their referral patterns is a meaningful indicator of his professional standing within the region.
Dr Shobhit Baijal: Consultant Medical Oncologist in Birmingham
Dr Shobhit Baijal is a Consultant Medical Oncologist based across Birmingham, Solihull, and Sutton Coldfield, and is one of the most experienced lung cancer oncologists serving the West Midlands. His clinical focus sits firmly within the drug-based treatment of thoracic and gastrointestinal malignancies, and his specific lung cancer expertise encompasses immunotherapy, targeted therapy, precision chemotherapy, and the management of mesothelioma alongside standard non-small cell and small cell lung cancer presentations. He practices at several well-appointed private facilities across the Birmingham area, making him an accessible specialist for patients throughout the region.
Systemic Therapy and Targeted Treatment
Dr Baijal's clinical approach is shaped by a strong command of systemic therapy, reflecting the depth of his background in medical oncology. In the current era of lung cancer management, systemic treatment frequently forms the backbone of care, whether that involves first-line immunotherapy for patients with high PD-L1 expression, targeted agents for those with EGFR or ALK mutations, or combination regimens for patients with more advanced disease presentations. His familiarity with the rapidly evolving landscape of thoracic drug therapies positions him well to offer patients the most current pharmacological options, and his experience with mesothelioma adds a further dimension of expertise in the broader field of thoracic malignancies.
Practice Locations and Patient Accessibility
Dr Baijal's multi-site practice across Birmingham, Solihull, and Sutton Coldfield reflects the geographic range of patients he serves across the West Midlands. For those in the Birmingham conurbation and surrounding areas, accessing a consultant-level medical oncologist without travelling to London is a practical advantage that carries real weight for patients managing the physical and logistical demands of cancer treatment. His acceptance of patients with a range of thoracic diagnoses, from primary lung cancer to mesothelioma and metastatic disease, means that his clinical caseload is varied and that his experience is correspondingly broad.
Dr Baijal works within the well-established private oncology infrastructure of the West Midlands, and his caseload reflects the region's clinical diversity. His familiarity with immunotherapy protocols, molecularly guided agent selection, and the management of rarer thoracic malignancies such as mesothelioma gives him a broad clinical reference point from which to approach each individual presentation. For patients across the Birmingham area seeking a consultant medical oncologist with a strong track record in systemic treatment, Dr Baijal is a well-placed and experienced choice.
Finding the Right Specialist Is the First Step Toward the Best Possible Outcome
Choosing a lung cancer oncologist is a deeply personal decision, shaped by geography, the nature of the diagnosis, the treatments under consideration, and the kind of clinical relationship a patient is looking for. The specialists featured in this guide represent the breadth of high-quality thoracic oncology practice available across the UK, from London-based consultants with world-class training and cutting-edge radiotherapy capability to regional practitioners offering comparable expertise closer to home. For patients anywhere in the country, the first step is the same: seek a specialist consultation as early as possible, come prepared with questions, and give yourself the strongest possible foundation from which to move forward with a treatment plan that is genuinely tailored to your individual case.